Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | MME | P08473 | 6/20 | 0.53 |
| ▸ | LAP3 | P28838 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3777970 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL30676222 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL30453786 | 0.97 | ALDH1A1 (0.53) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL29449455 | 0.92 | MME (0.56) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL31031454 | 0.91 | MME (0.56) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL30454933 | 0.91 | ALDH1A1 (0.47) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL29531317 | 0.91 | ALDH1A1 (0.47) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL8945568 | 0.89 | PDCD1LG2 (0.53) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL30381706 | 0.89 | PDCD1LG2 (0.47) | ALDH1A1MEN1LMNAKMT2AMME | |
| Leu-Leu SCHEMBL6044006 | 0.89 | ALDH1A1 (0.60) | ALDH1A1MEN1LMNAKMT2AMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7846902-B2 | Dipeptide-comprising composition for oral administration | KYOWA HAKKO BIO CO., LTD. (JP) | 2010-12-07 | — | — | US | disclosed |
| US-20080305151-A1 | Dipeptide-Comprising Composition for Oral Administration | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
| EP-1941896-A1 | DIPEPTIDE-CONTAINING COMPOSITION FOR ORAL ADMINISTRATION | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-07-09 | — | — | EP | disclosed |
| WO-1992010562-A1 | GANODERMA LUCIDIUM IY009 WHICH PRODUCES PROTEOGLYCAN (G009) HAVING EFFECT OF ENHANCING ANTITUMOR IMMUNITY | IL-YANG PHARMACEUTICAL CO., LTD. (KR) | 1992-06-25 | — | — | WO | disclosed |